OLA
ELV icon

Oliver Luxxe Assets’s Elevance Health ELV Stock Holding History

Oliver Luxxe Assets’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-4,960
Closed -$2.2M – 170
2023
Q2 		$2.2M Sell
4,960
-1,287
-21% -$594K 0.55% 63
2023
Q1 		$2.87M Buy
6,247
+181
+3% +$86.1K 0.76% 50
2022
Q4 		$3.11M Buy
6,066
+86
+1% +$43.7K 0.87% 44
2022
Q3 		$2.72M Buy
5,980
+122
+2% +$58.4K 0.85% 48
2022
Q2 		$2.83M Sell
5,858
-78
-1% -$38.6K 0.84% 44
2022
Q1 		$2.92M Buy
+5,936
New +$2.71M 0.74% 50

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Oliver Luxxe Assets's ELV Position: Q3 2023 in Review

Oliver Luxxe Assets sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 4,960 shares — an estimated $2.2M sold.

Oliver Luxxe Assets first reported a position in ELV in Q1 2022 and held it in 6 quarters. The position peaked at $3.11M in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Oliver Luxxe Assets reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Oliver Luxxe Assets sold 4,960 Elevance Health shares in Q3 2023, an estimated $2.2M.
  • Oliver Luxxe Assets first reported a position in Elevance Health in Q1 2022 and held it in 6 quarters.
  • Oliver Luxxe Assets's Elevance Health position peaked at $3.11M in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Oliver Luxxe Assets's 13F filing for Q3 2023, filed 9 Nov 2023.